Condensed Consolidated Statements of Changes in Redeemable Perpetual Preferred Stock and Stockholders' Equity (unaudited) - USD ($) shares in Thousands, $ in Thousands	Total		Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Temporary equity, beginning balance (in shares) at Dec. 31, 2024	460
Temporary equity, beginning balance at Dec. 31, 2024	$ 406,931
Increase (Decrease) in Temporary Equity [Roll Forward]
Preferred cumulative dividends plus accretion (in shares)	8
Preferred cumulative dividends plus accretion	$ 14,443
Temporary equity, ending balance (in shares) at Mar. 31, 2025	468
Temporary equity, ending balance at Mar. 31, 2025	$ 421,374
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2024			151,952
Stockholders' equity, beginning balance at Dec. 31, 2024	(118,096)		$ 151	$ 297,780	$ (370,624)	$ (45,403)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units (in shares)			518
Vesting of restricted stock units	0
Employee purchase plan (in shares)			43
Employee purchase plan	222			222
Equity-based compensation	2,798			2,798
Tax withholding related to vesting of equity-based compensation	(278)			(278)
Preferred cumulative dividends plus accretion	(14,443)			(14,443)
Net income	16,746				16,746
Foreign currency translation	15,277	[1]				15,277
Stockholders' equity, ending balance (in shares) at Mar. 31, 2025			152,513
Stockholders' equity, ending balance at Mar. 31, 2025	$ (97,774)		$ 151	286,079	(353,878)	(30,126)
Temporary equity, beginning balance (in shares) at Dec. 31, 2025	490
Temporary equity, beginning balance at Dec. 31, 2025	$ 466,728
Increase (Decrease) in Temporary Equity [Roll Forward]
Preferred cumulative dividends plus accretion (in shares)	8
Preferred cumulative dividends plus accretion	$ 15,537
Temporary equity, ending balance (in shares) at Mar. 31, 2026	498
Temporary equity, ending balance at Mar. 31, 2026	$ 482,265
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2025			152,780
Stockholders' equity, beginning balance at Dec. 31, 2025	(206,340)		$ 152	226,848	(422,859)	(10,481)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units (in shares)			912
Vesting of restricted stock units	0		$ 3	(3)
Employee purchase plan (in shares)			42
Employee purchase plan	298			298
Equity-based compensation	3,881			3,881
Tax withholding related to vesting of equity-based compensation	(1,002)			(1,002)
Preferred cumulative dividends plus accretion	(15,537)			(15,537)
Net income	1,997				1,997
Foreign currency translation	2,322	[1]				2,322
Stockholders' equity, ending balance (in shares) at Mar. 31, 2026			153,734
Stockholders' equity, ending balance at Mar. 31, 2026	$ (214,381)		$ 155	$ 214,485	$ (420,862)	$ (8,159)

[1] There are no tax effects on foreign currency adjustments.